Novo's Approach to Weight Loss

We start thinking about these class of drugs as a heart medicine, sort of like we think about statins. Does that make a difference? And is that, I mean, if that's how people start treating patients with these medicines as a sort of for cardiovascular benefit, does that just make the category that much bigger? Ellen: Getting to the or getting an answer to that question is important for determining kind of how big this class of drugs can be vis a vis obesity.